[Form 4] CAMPBELL'S Co Insider Trading Activity

Rhea-AI Filing Summary

Form 4: Director Fabiola R. Arredondo reported a transaction in Campbells Co (CPB). On 09/25/2025 she acquired 1,325 shares of Common Stock at a reported price of $0. Following the transaction she beneficially owned 28,331 shares. The filing indicates the reporter is a Director and was signed by Marci K. Donnelly, Attorney-in-Fact, on 09/26/2025.

Insights

Financial Analyst

TL;DR: A director reported a non-derivative acquisition of 1,325 shares, raising her total to 28,331 shares; transaction price reported as $0.

The filing documents a small, outright acquisition by a director of common stock rather than an option exercise or derivative. The reported price of $0 is unusual in equity purchase reporting and may reflect a grant, stock distribution, or clerical reporting convention; the Form 4 itself does not explain the price. The transaction size (1,325 shares) is modest relative to large-cap market caps and does not by itself imply a material change to ownership or control.

Corporate Governance Expert

TL;DR: Director-level insider disclosed acquisition; disclosure meets Section 16 reporting but lacks narrative on consideration or source.

From a governance perspective, timely disclosure of the directors transaction is appropriate and consistent with Section 16 obligations. The filing identifies the reporter as a director and provides post-transaction beneficial ownership. The absence of an explanation for the $0 price in the remarks section limits clarity about whether this was a grant, dividend reinvestment, or reporting artifact. The document contains the required signature by an attorney-in-fact.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider ARREDONDO FABIOLA R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,325	$0.00	--

Holdings After Transaction: Common Stock — 28,331 shares (Direct)

Footnotes (1)

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ARREDONDO FABIOLA R

(Last) (First) (Middle)

ONE CAMPBELL PLACE

(Street)

CAMDEN NJ 08103

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CAMPBELL'S Co [ CPB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/25/2025		A		1,325	A	$0	28,331	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Marci K. Donnelly, Attorney-in-Fact	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.